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Long non-protein-coding RNAs (lncRNAs) are
proposed to be the largest transcript class in the
mouse and human transcriptomes. Two important
questions are whether all lncRNAs are functional and
how they could exert a function. Several lncRNAs
have been shown to function through their product,
but this is not the only possible mode of action. In
this review we focus on a role for the process of
lncRNA transcription, independent of the lncRNA
product, in regulating protein-coding-gene activity in
cis. We discuss examples where lncRNA transcription
leads to gene silencing or activation, and describe
strategies to determine if the lncRNA product or its
transcription causes the regulatory effect.
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Transcriptional interferenceof tissue and developmental-specific transcription factorsLncRNAs - a new layer of genome regulatory
information
It is now well appreciated that less than two percent of
the human genome codes for proteins and the majority
of the genome gives rise to non-protein-coding RNAs
(ncRNAs) [1], which are predicted to play essential roles
in a variety of biological processes [2,3].
The focus of this review is long ncRNAs (known as
lncRNAs), which constitute the biggest class of ncRNAs
with approximately 10,000 lncRNA genes so far anno-
tated in humans [4]. lncRNAs are RNA polymerase II
(RNAPII) transcripts that lack an open reading frame
and are longer than 200 nucleotides. This size cut-off
distinguishes lncRNAs from small RNAs such as
microRNAs, piwi-interacting RNAs (piRNAs), small nu-
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reproduction in any medium, provided the or(siRNAs) and arises from RNA preparation methods that
capture RNA molecules above this size. Although the
function of most lncRNAs is unknown, the number of
characterized lncRNAs is growing and many publica-
tions suggest they play roles in negatively or positively
regulating gene expression in development, differenti-
ation and human disease [2,5-10]. lncRNAs may regulate
protein-coding (pc) gene expression at both the post-
transcriptional and transcriptional level. Posttranscrip-
tional regulation could occur by lncRNAs acting as
competing endogenous RNAs to regulate microRNA
levels as well as by modulating mRNA stability and
translation by homologous base pairing, or as in the ex-
ample of NEAT1 that is involved in nuclear retention of
mRNAs [11]. In this review we focus on the regulation
at the transcriptional level.Modes of transcriptional regulation by lncRNAs
Regulation of transcription is considered to be an interplay
(TFs) and chromatin modifying factors acting on enhancer
and promoter sequences to facilitate the assembly of the
transcription machinery at gene promoters. With a grow-
ing number of lncRNAs implicated in transcriptional gene
regulation, this view may need refinement to include net-
works of tissue and developmental-stage specific lncRNAs
that complement known regulators to tightly control gene
expression and thereby organism complexity [12,13].
Transcriptional regulation by lncRNAs could work either
in cis or in trans, and could negatively or positively control
pc gene expression. lncRNAs work in cis when their ef-
fects are restricted to the chromosome from which they
are transcribed, and work in trans when they affect genes
on other chromosomes.Regulation in trans
Some significant examples of lncRNAs that act in trans
are those that can influence the general transcriptional
output of a cell by directly affecting RNAPII activity
(Figure 1a,b). One example is the 331 nucleotide 7SKral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1741-7007/11/59lncRNA, which represses transcription elongation by
preventing the PTEFβ transcription factor from phos-
phorylating the RNAPII carboxy-terminal domain
(CTD) [14] (Figure 1a). Another example is the 178 nu-
cleotide B2 lncRNA, a general repressor of RNAPII ac-
tivity upon heat shock [15]. The B2 lncRNA acts by
binding RNAPII and inhibiting phosphorylation of its
CTD by TFIIH, thus disturbing the ability of RNAPII to
bind DNA [16,17].RNAPII
P
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orientation. For details see text.Regulation in trans can also act locus-specifically. While
the ability of lncRNAs to act locus-specifically to regulate
a set of genes was first demonstrated for imprinted genes
where lncRNA expression was shown to silence from one
to ten flanking genes in cis [18-20], lncRNAs that lie out-
side imprinted gene clusters, such as the HOTAIR
lncRNA, were later found also to have locus-specific ac-
tion. HOTAIR is expressed from the HOXC cluster and
was shown to repress transcription in trans across 40 kbRE
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Polycomb repressive complex 2 (PRC2) and is required
for repressive histone H3 lysine-27 trimethylation
(H3K27me3) of the HOXD cluster. Targeting of epigenetic
modifiers (EMs) by lncRNAs provided a much sought
after model to explain how EMs gain locus specificity (Fig-
ure 1d), and has since been suggested as a general mech-
anism for trans-acting lncRNAs [22,23].
Regulation in cis
In contrast to trans-acting lncRNAs, which act via their
RNA product, cis-acting lncRNAs have the possibility to
act in two fundamentally different modes. The first mode
depends on a lncRNA product. The major example of gen-
eral cis-regulation is induction of X inactivation by the Xist
lncRNA in female mammals. Xist is expressed from one of
the two X chromosomes and induces silencing of the
whole chromosome [24] (Figure 1c). As an example of
locus-specific regulation it has been proposed that enhan-
cer RNAs activate corresponding genes in cis via their
product [25]. A well-studied cis-acting lncRNA acting
through its product is the human HOTTIP lncRNA that is
expressed in the HOXA cluster and activates transcription
of flanking genes. HOTTIP was shown to act by binding
WDR5 in the MLL histone modifier complex, thereby
bringing histone H3 lysine-4 trimethylation (H3K4me3) to
promoters of the flanking genes [26]. Such a mechanism in
which a nascent lncRNA transcript binds and delivers epi-
genetic modifiers to its target genes while still attached to
the elongating RNAPII is generally termed ‘tethering’ and
is often used to explain cis-regulation by lncRNAs [23,27]
(Figure 1e). It was also proposed to act in plants. In
Arabidopsis thaliana, the COLDAIR lncRNA is initiated
from an intron of the FLC pc gene and silences it by
targeting repressive chromatin marks to the locus to con-
trol flowering time [28].
In contrast, the second mode of cis regulation by
lncRNAs involves the process of transcription itself, which
is a priori cis-acting (Figure 1f). Several lines of evidence
suggest that the mere process of lncRNA transcription can
affect gene expression if RNAPII traverses a regulatory
element or changes general chromatin organization of the
locus. In this review we discuss this underestimated role
for lncRNA transcription in inducing protein-coding gene
silencing or activation in cis, and overview possible mecha-
nisms for this action in mammalian and non-mammalian
organisms. Finally, we describe experimental strategies to
distinguish lncRNAs acting as a transcript from those act-
ing through transcription.
Mechanisms by which lncRNA transcription
silences gene expression
Transcription-mediated silencing, also referred to as
‘transcriptional interference’ (TI), is defined here as acase in which the act of transcription of one gene can
repress in cis the functional transcription of another
gene [29,30]. TI has been reported in unicellular and
multicellular organisms [30]. Mechanistic details are still
largely unclear, but TI could theoretically act at several
stages in transcription: by influencing enhancer or pro-
moter activity or by blocking RNAPII elongation, spli-
cing or polyadenylation. All that would be required is
that the RNA polymerase (RNAPII) initiated from an
'interfering' promoter traverses a 'sensitive' DNA regula-
tory sequence. TI has mainly been reported at over-
lapped promoters [31-35], but there are also examples
where TI acts downstream of the promoter. In mouse,
overlapping transcription controls polyadenylation
choice of two imprinted genes [36,37]. In Saccharomyces
cerevisiae, collisions between elongating antisense
RNAPIIs can lead to stalling of both polymerases that is
resolved by ubiquitylation-directed proteolysis, and this
has been proposed to be a regulatory mechanism [38].
However, it is unknown if RNAPII collisions occur suffi-
ciently frequently in vivo in yeast or other organisms to
offer a means of regulating convergent genes, or if this
mechanism could lead to an interfering RNAPII elimin-
ating its sensitive collision partner. Despite these exam-
ples, the most common reports of TI concern an
overlapped promoter, and in the following sections we
describe studies investigating the molecular mechanisms
underlying interference at the promoter.
Transcriptional interference acting by promoter
nucleosome repositioning
DNA in the nucleus is organized into chromatin with
the organizational scaffold consisting of nucleosomes,
each with two copies of H3, H4, H2A and H2B histones
[39]. Nucleosomes can be densely packed, interfering
with protein-DNA interactions, or relaxed, facilitating
these interactions [40]. The transcription process, which
generates single-stranded DNA as RNAPII progresses
along a gene locus, can directly affect nucleosome posi-
tioning [41-43] (reviewed in [44,45]). Thus, lncRNA
transcription could cause TI by depositing nucleosomes
in a manner unfavorable for TF binding on promoters
or enhancers. An example of this mechanism is the si-
lencing of the yeast SER3 pc gene by transcriptional
overlap by the SRG1 lncRNA (Figure 2a) [46]. SRG1
transcription increases nucleosome density at the over-
lapped SER3 promoter. Deletion of three transcription
elongation factors that are associated with the elongating
polymerase and are necessary for nucleosome reposi-
tioning (SPT16, SPT6, SPT2) [47-49] abolished the silen-
cing effect without stopping transcription of the
overlapping lncRNA SRG1 [50,51], indicating the neces-
sity of chromatin reorganization for silencing. In con-
trast, deletion of epigenetic modifiers (such as SET1/2
(a) LncRNA transcription causes increased nucleosome density (yeast) 
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Figure 2. Transcription interference-mediated silencing by chromatin changes. (a) Top: in yeast the absence of SRG1 lncRNA allows
transcription machinery assembly at the SER3 protein coding gene promoter. Bottom: SRG1 lncRNA transcription causes dense nucleosome
packing over the downstream SER3 pc gene promoter that blocks TF binding and pc gene expression. (b) Top: in yeast the absence of IRT1
lncRNA allows IME1 pc gene expression. Bottom: RNAPII transcribing the IRT1 lncRNA carries EMs that deposit repressive histone modifications at
the IME1 promoter (EM1 - methyltransferases). These modifications allow the binding of other EMs that remove active histone modifications (EM2 -
deacetylases) and cause a repressive chromatin environment that blocks TF binding leading to silencing. (c) Top: in a healthy human, LUC7L
and HBA2 pc genes do not overlap and are both expressed. Bottom: a chromosomal deletion of the LUC7L transcriptional stop signal (red
‘stop’ box) causes transcription of the LUC7L pc gene through the promoter of the HBA2 pc gene. By an unknown mechanism this aberrant
transcription causes DNA methylation and silencing of the HBA2 promoter. For details see Figure 1g and text.
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described later) did not affect silencing, showing that nu-
cleosome positioning, but not changes in histone modifica-
tions, is responsible for repression. The experiments did
not directly exclude a role for the SRG1 lncRNA product,
but the silencing can be explained solely by the process of
transcription [44,45]. TI by nucleosome repositioning may
be a general mechanism in yeast, as the RNAPII elongation
and chromatin organization factors responsible for SER3
silencing are also known to be involved in the suppression
of transcription initiation from cryptic promoters within
the body of actively transcribed genes [52,53]. Since genes
controlling RNAPII elongation and chromatin organization
are largely conserved, it is possible that lncRNAs could use
similar nucleosome repositioning silencing in mammals.
This is supported by the example that chromatin reassem-
bly factors are necessary for silencing an HIV provirus
when integrated into an actively transcribed host gene in a
human cell system [54].
Transcriptional interference acting by promoter
histone modifications
Promoter associated nucleosomes carry post-translational
histone tail modifications that reflect the activity state of
the promoter and also influence accessibility of DNA
binding factors involved in transcription [55]. Active gene
promoters correlate with H3 and H4 acetylation and with
H3K4me3, while inactive promoters do not and, in mam-
mals, they also gain repressive histone marks such as
H3K9me3 or H3K27me3. Some histone modifying en-
zymes have been shown to bind and travel with elongating
RNAPII [56,57], so it is possible that lncRNA transcription
can induce TI by affecting histone modifications at the pro-
moter of an overlapped target gene. For example, in yeast
the SET1/2 methyltransferases, which induce H3K4me2
and H3K36me3 in the body of transcribed genes, bind and
travel with elongating RNAPII [58-60]. These modifica-
tions in turn recruit the SET3C/RPD3S histone deacetylase
complexes to create a chromatin environment repressive
for transcription initiation [61-63].
Two studies indicate that this is a mechanism used by
lncRNAs to induce TI in yeast. In the first study the
IME1 pc gene, which induces gametogenesis in diploid
S. cerevisiae cells but is repressed in haploid cells, was
shown to be silenced by the IRT1 lncRNA that overlaps
its promoter [64]. Genetic experiments repositioning the
IRT1 lncRNA distant from IME1 on the same chromo-
some showed that IRT1 transcriptional overlap of the
IME1 promoter is necessary for silencing. Interestingly,
the instability of the IRT1 lncRNA product and its non-
specific cellular localization indicated the lncRNA prod-
uct is unlikely to play a role in the silencing mechanism.
Instead, IRT1 lncRNA transcription through the IME1
promoter reduced recruitment of the essential POG1transcription factor, increased nucleosome density and
induced the SET1/2 mediated cascades of histone modi-
fications, which were shown to be necessary for silencing
[64] (Figure 2b). In the second study lncRNA transcrip-
tion was shown to be causative for silencing of the
GAL1 and GAL10 genes, involved in galactose metabolism
in S. cerevisiae. GAL10 and GAL1 are divergently tran-
scribed from a bidirectional promoter. The 4 kb lncRNA,
called GAL10-ncRNA, initiates in the body of the GAL10
gene, and is transcribed through the GAL10/GAL1
promoter antisense to the GAL10 gene. GAL10-ncRNA
transcription induces SET2-mediated establishment of
H3K36me3 along its gene body, thereby recruiting RPD3S-
dependent deacetylation that resulted in reduced transcrip-
tion factor binding and repression of the GAL1/GAL10
promoter [65]. Both SET3C and RPD3S are proposed to
have a general role in repressing cryptic promoters within
gene bodies [61,66] and a genome-wide study implied a
role for SET3C in overlapping lncRNA-mediated silencing
of a set of pc genes in yeast [66]. This indicates that the
mechanism described above might be widely used to
control gene expression in yeast. Although similar studies
have not been described for the mammalian genome,
H3K36me3 marks the body of transcribed genes in mam-
mals, raising the possibility that such TI mechanisms could
be conserved [56,57].
Transcriptional interference acting by promoter
DNA methylation
In mammalian genomes DNA methylation is generally as-
sociated with silent CpG island promoters, but the majority
of CpG island promoters remain methylation free inde-
pendent of their expression status [67-69]. The process of
de novo methylation depends on the DNMT3A/3B
methyltransferases and the catalytically inactive DNMT3L
homologue and requires histones lacking H3K4me3, ensur-
ing that active promoters remain methylation-free [70].
Notably, while DNA methylation at the promoter blocks
transcription initiation, methylation in the gene body does
not. Two important examples in humans based on genetic
analyses indicate that DNA methylation can be involved in
TI-induced silencing, although the causality between DNA
methylation and silencing is still a matter of discussion
[67]. One study of a patient with inherited α-thalassemia
identified a deletion of the LUC7L 3' end that allowed aber-
rant transcription of LUC7L through the downstream
HBA2 gene, causing its silencing and the disease pheno-
type [71] (Figure 2c). Mouse models that mimicked the de-
leted genomic locus showed that the main cause of
silencing was the acquisition of DNA methylation at the
HBA2 promoter. Notably, DNA methylation acquisition
was not simply the consequence of an inactive promoter,
as removal of HBA2 transcription by deleting its TATA
box did not induce methylation. The sequence of the
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not essential for HBA2 silencing, as replacing the LUC7L
gene body with another protein-coding gene did not re-
move the repressive effect. In a second example, a subset
of Lynch syndrome patients display DNA methylation and
inactivation of the mismatch repair MSH2 gene that corre-
lates with aberrant transcription from the flanking EPCAM
gene that carries a 3' deletion [72].
In both these examples, the molecular details of
methylation establishment and the mechanism by which
the methylation machinery targets the overlapped pro-
moter are yet unknown. However, the data so far show
that it is a cis-acting mechanism as only the allele carry-
ing the deletion silences the overlapped protein-coding
gene. In addition, although a role for the aberrant RNA
product was not excluded, it appears unlikely that
mutation-induced transcription of two independent
intergenic chromosomal regions in the described dis-
eases produces lncRNA products with similar repressive
functions. Interestingly, the silencing of imprinted pc
genes by lncRNAs is also often correlated with the gain
of DNA methylation on the silent pc gene promoter
[73]. In the case of the Igf2r gene, this DNA methylation
mark is not necessary for initiation or maintenance of
the silent state but seems to play a role in re-enforcing
the silent state [35,74].
Transcriptional interference in the absence of
chromatin changes at the silenced promoter
In addition to RNAPII acting as a carrier of chromatin
modifying enzymes, other TI models predict that
RNAPII from one promoter traversing across another
promoter can interfere with its activity without introdu-
cing chromatin changes [30,75,76]. An indication that
such a mechanism can be used by lncRNAs in mammals
comes from a study that used a genetic approach to dis-
sect the silencing function of the imprinted mouse Airn
lncRNA [77,78]. Airn is an inefficiently spliced 118 kb
lncRNA expressed on paternally inherited chromosomes
that overlaps and silences the promoter of the Igf2r pc
gene - a dose-sensitive and essential embryonic growth
suppressor [18,79] (Figure 3a). To determine if Airn
transcription or its lncRNA product were required for
silencing, homologous recombination in embryonic stem
cells was used to shorten the length of Airn, either be-
fore or after the Igf2r promoter, by insertion of a
polyadenylation cassette [35]. Notably, only shortened
Airn variants that traversed the Igf2r promoter induced
silencing. Furthermore, while Igf2r silencing is normally
accompanied by DNA methylation, repressive histone
marks and chromatin compaction of the silent Igf2r pro-
moter [80,81], Igf2r silencing was not dependent on
DNA methylation - in contrast to the silencing of HBA2
by aberrant LUC7L transcription described above.Instead, Airn transcriptional overlap interfered with the
accumulation of functional RNAPII on the Igf2r pro-
moter in the presence of open chromatin [35]. Add-
itional support for Igf2r silencing by Airn transcriptional
interference is provided by genetic experiments that
used an inducible Airn promoter to silence Igf2r at dif-
ferent stages of embryonic stem cell differentiation [74].
The demonstration that Airn transcription is continu-
ously required for Igf2r silencing and that its silencing
efficiency decreases when the Igf2r promoter is strongly
expressed provides support for a model whereby RNAPII
initiated from an 'interfering' promoter interferes with
transcription initiation from a 'sensitive' promoter.
To date, other examples of lncRNAs acting by this
mechanism in mammals are lacking. It has been sug-
gested that silencing of an alternative promoter of the
mouse fpgs pc gene is an example of transcription indu-
cing silencing without introducing chromatin changes
[82], but this system has not been subject to a similar
genetic analysis and alternative explanations remain pos-
sible. How RNAPII from an interfering promoter is able
to suppress functional transcription of the overlapped
promoter remains to be determined, but stalling of the
interfering RNAPII elongating over the sensitive pro-
moter has been suggested to block access of essential
TFs [30,83]. This mechanism should not be confused
with the phenomenon of genome-wide RNAPII pausing
at promoters, which represents an intermediate step be-
tween RNAPII initiation and elongation phases and
might be a common mechanism regulating differential
gene expression in metazoans [84,85].
The above examples describe repressive effects from
RNAPII transcribing lncRNAs through promoters of
silenced genes. However, transcriptional interference
might also disrupt enhancer function when RNAPII tra-
verses an enhancer, and this is an attractive model to ex-
plain the repression of a cluster of genes by a lncRNA in
a tissue-specific manner [75] (Figure 3b). This situation
arises in two imprinted gene clusters where the Airn and
Kcnq1ot1 lncRNAs each overlap one gene, but silence
multiple genes in cis in a tissue-specific manner. The re-
pressive histone EHMT2 methyltransferase has been
shown to be necessary in the placenta to silence one of
the three genes controlled by Airn [86]. The Kcnq1ot1
lncRNA has been shown to silence multiple genes in
placental cells by the action of repressive POLYCOMB
histone modifying enzymes [87,88]. In both cases, a dir-
ect role for the lncRNA in targeting the histone modify-
ing complexes was proposed, based on the findings that
the lncRNAs interact with the respective histone modify-
ing complex. This correlation-based evidence is, how-
ever, not sufficient to rule out the possibility that both
lncRNAs silence distant genes by transcription alone
(reviewed in [75,76]). In support of a transcription-based
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Figure 3. Transcription interference-mediated silencing without chromatin changes. (a) Top: a wild-type maternal allele does not express
Airn lncRNA as its promoter is repressed by a DNA methylation imprint, thus allowing the Igf2r gene to be active. Middle: on the wild-type
paternal allele Airn transcription overlaps with and silences the Igf2r pc gene promoter, independent of the Airn lncRNA product. The silent Igf2r
promoter is marked by increased nucleosome density and DNA methylation in the absence of active histone modifications. Bottom: increased
nucleosome density, loss of active histone marks and DNA methylation are not necessary for Igf2r repression as demonstrated by the FAP allele
that moved the Airn promoter close to the Igf2r promoter and silenced Igf2r in the absence of repressive chromatin features. (b) Top: a
hypothetical enhancer activates a pc gene by direct long-range DNA interactions. Bottom: transcription of a lncRNA overlapping the enhancer
interferes with the DNA interaction and thereby silences the pc gene. For details see Figure 1g, Figure 2d and text.
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gene by regulating chromatin flexibility and access to en-
hancers [89]. This is consistent with a two-step model
whereby lncRNA transcription initiates silencing of non-
overlapped genes by enhancer interference, then repres-
sive histone modifying enzymes maintain that silencing.lncRNA transcription creating a permissive
chromatin environment
Enhancers are genetic elements that bind transcription
factors facilitating transcription machinery assembly at
nearby promoters [90,91]. RNAPII transcripts up to 2 kb
long are transcribed bi-directionally from some neuronal
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scription of eRNAs positively correlated with expression
of nearby mRNAs and a model was proposed, but not
yet experimentally tested, in which their transcription
establishes a chromatin landscape that supports enhan-
cer function (Figure 4a). lncRNA transcription, either by
opening chromatin or inhibiting repressor protein bind-
ing, could similarly result in gene or locus activation.
One example of this is the process of V(D)J recombin-
ation, which joins elements of the V, D and J multigene
family by chromosomal rearrangements to create func-
tional B cell immunoglobulins and T cell receptors [93]
(Figure 4b). The V, D and J genes lie next to each other
on the same chromosome and antisense intergenic tran-
scription through these genes is detected prior to the re-
combination process [94]. Genetic experiments have
shown that intergenic lncRNA transcription is required
for both B and T cell V(D)J recombination [95,96]. Simi-
lar correlations between intergenic transcription and
gene expression were observed for the mouse β-globin
locus [97] where promoter deletion experiments showed
that lncRNA transcription was responsible for stable, ac-
tive and hyper-accessible chromatin [98].
lncRNA transcription and locus activation
Other examples indicate that lncRNA transcription acti-
vates gene expression by blocking access of repressor
complexes to chromatin. In Drosophila, intergenic non-
coding transcription at the BITHORAX complex (BX-C)
is implicated in reversing POLYCOMB group (PCG)-me-
diated gene silencing and is correlated with an active
chromatin state [99]. This mode of action was later sug-
gested to be a general mechanism where the act of tran-
scription serves as an epigenetic switch that relieves
PCG-mediated gene silencing by recruiting epigenetic
modifiers to induce gene expression and generate stable
and heritable active chromatin [100]. In line with this hy-
pothesis, intergenic transcription through PCG response
elements (PREs) in the BX-C cluster is not only found dur-
ing embryogenesis but also in late stage larvae, indicating
that continuous transcription is required to keep genes ac-
tive [101]. In mouse and human, a similar role for PRE
transcription has been proposed. An analysis of lncRNA
transcription in the human HOXA cluster revealed a posi-
tive correlation between lncRNA transcription and the
loss of PCG/chromatin interactions that precedes HOXA
gene activation [102]. Additionally, lncRNAs have been
identified at promoter regions of PCG-regulated genes in
mouse cells; while their role is not yet clear, it has been
suggested that they either promote or interfere with PCG
binding at target genes [103,104].
A further example of a lncRNA mediating chromatin
opening was described at the S. cerevisiae PHO5 gene. Tran-
scription of an antisense lncRNA that initiates near the3’end of PHO5 and overlaps its gene body and promoter is
associated with rapid activation of PHO5 by enabling nu-
cleosome eviction. Biochemical inhibition of RNAPII elong-
ation as well as genetic disruption of lncRNA elongation
demonstrated a direct role in PHO5 activation [105]. The as-
sociation of lncRNA transcription with gene activation
needs, however, to be considered within the framework that
most protein-coding gene promoters in yeast and mamma-
lian cells give rise to a bidirectional antisense lncRNA tran-
script [106,107]. To date it is unclear if promoter-associated
bidirectional lncRNAs represent spurious transcription in
the context of open chromatin [108,109] or is required to
maintain open chromatin. In the latter case enhanced TF
binding ensures accessible chromatin that allows more con-
stant pc gene expression within a cell population [110]
(Figure 4c).
Strategies for distinguishing a role for the lncRNA
product from that of its transcription
Following genome-wide lncRNA mapping, functional
studies so far have mainly focused on lncRNA products
[7,111]. As it becomes clear that lncRNAs can act through
their transcription, it is important to identify strategies to
determine the function and mode of action of each par-
ticular lncRNA. One common starting point to determine
lncRNA function has been RNA interference (RNAi)-me-
diated knockdown, despite long-standing observations
that the RNAi machinery in mammalian cells is located in
the cytoplasm [112]. While there is evidence that some
RNA-induced silencing complex (RISC) components are
found in the nucleus, functional complexes are specifically
loaded in the cytoplasm, prohibiting the application of
RNAi strategies for nuclear localized lncRNAs [113]. In
contrast, antisense oligonucleotides (ASO) that work via
an RNaseH-dependent pathway will deplete nuclear-
localized lncRNAs [114,115]. However, three additional
points of caution should be noted. First, non-specific ef-
fects arising from nuclear transfection reagents [116] have
confused some observations. One critical validation step
for knockdown studies would be a rescue experiment in
which the lncRNA, modified to be invulnerable to the
knockdown, is expressed as a transgene under the same
transfection conditions [111]. Second, some results have
highlighted major differences when functional studies
used post-transcriptional depletion strategies in cell lines
in contrast to genetic studies in the organism. Notable ex-
amples are Neat1 [117], Malat1 [116,118,119] and Hotair
[120] where studies of mice carrying genetically disrupted
alleles of these three lncRNAs failed to reproduce pheno-
types deduced from cell lines following RNAi, ASO or
over-expression studies. Third, while knockdown experi-
ments may elucidate the function of lncRNAs acting
through their product, the function of cis-acting lncRNAs
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Figure 4. Transcription of lncRNA creates permissive chromatin environment. (a) Top left: an inactive enhancer with closed chromatin
cannot activate the pc gene. Top right, bottom left: transcription of the enhancer opens chromatin. Bottom right: open chromatin at the
enhancer allows TF binding and interaction with and activation of the pc gene promoter. (b) VDJ recombination. From top to bottom: 1, D and J
segments are joined and the V region has closed chromatin; 2, antisense transcription through the V region opens the chromatin and allows
recombination factors to bind; 3, a V segment is joined to the DJ segment. (c) Top: at a bidirectional promoter a lncRNA and a pc gene are
transcribed in opposite directions. The promoter is always in an open chromatin conformation as either the lncRNA or the pc gene is transcribed,
which is thought to reduce transcriptional noise. Bottom: a unidirectional pc gene promoter can acquire a closed chromatin conformation due to
stochastic TF binding, which is thought to increase transcriptional noise. Noise defines the variation of expression of a transcript between
genetically identical cells caused by the stochastic binding of TFs regulated by the local chromatin environment. For details see Figure 1g,
Figure 2d, Figure 3c and text.
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http://www.biomedcentral.com/1741-7007/11/59Features such as subcellular localization, half-life and
steady-state abundance would form a good basis to allow
functional tests to be designed. In addition, knowledge of
the lncRNA splicing efficiency, conservation of splicing
pattern in multiple tissues and species, an estimation of
transcript repeat content and, finally, an accurate mapping
of lncRNA 5' and 3' ends are essential preliminary steps.
We have previously proposed that a subclass of lncRNAs,
‘macro’ lncRNAs, show RNA biology hallmarks such asinefficient splicing, extreme length, high repeat content,
lack of conservation and a short half-life. These features
are also indicators that the lncRNA product is less import-
ant than the act of transcription [121]. Once RNA biology
features are known, experiments can be designed to dis-
tinguish between a role for the lncRNA product or its
transcription.
From the caveats of posttranscriptional knockdown ex-
periments described above, it becomes clear that genetic
PP
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Figure 5. Strategies to distinguish between the function of a lncRNA product and its transcription. Both DNA strands are shown as
separate boxes to indicate a lncRNA transcribed from the top reverse strand, overlapping a pc gene transcribed from the bottom forward strand
in antisense orientation. A silencing function of the lncRNA can be predicted by an anti-correlating expression pattern. (a) Left: the lncRNA
silencing effect is mediated by tethering of the lncRNA product at the site of transcription, sequence-specific binding of an EM to the lncRNA
and guidance of the EM to the pc gene promoter. Right: silencing is mediated by a transcription process independent of the lncRNA product. (b)
Posttranscriptional knockdown removes the lncRNA product, thus reversing a lncRNA product-mediated effect (left) but not the transcription-
mediated effect (right). (c) lncRNA promoter deletion removes both lncRNA product- (left) and transcription-mediated (right) effects. (d)
Truncation experiments inserting transcriptional stop signals at different positions within the lncRNA gene identify the functional region of the
lncRNA gene (RNAPII is not shown). Left: lncRNA is only functional when the region corresponding to EM binding site is present. Right: lncRNA is
only functional when it crosses the promoter of the overlapped pc gene. For details see Figure 1g, Figure 2e, Figure 3c, Figure 4d and text.
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http://www.biomedcentral.com/1741-7007/11/59strategies are optimal for testing lncRNA function. These
strategies include manipulating the endogenous locus to
delete the promoter or the whole gene or to shorten its
length using inserted polyadenylation signals, as described
for several examples above. This may appear a formidable
task with the appreciation that lncRNAs in the human
genome may outnumber protein-coding genes [4];however, suitable cell systems already exist. These include
the use of haploid cell lines with transcriptional stop signal
insertions in most human genes that are screened by RNA
sequencing [122], gene targeting by engineered zinc-finger
nucleases [123] or CRISPR systems [124] or the use of
mouse embryonic stem cells that have efficient rates of
homologous targeting [125,126].
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http://www.biomedcentral.com/1741-7007/11/59These genetic strategies could be applied to determine if
the lncRNA is functional and if its function requires the
lncRNA product or only depends on the act of transcrip-
tion (Figure 5). Once these answers are obtained, it will be
useful to test whether additional chromatin features are
involved. This could include chromatin accessibility assays
to address nucleosome density in the regulated gene; and
mapping of histone modifications and DNA methylation,
and of the presence of RNAPII and other transcription
machinery components. These studies have been made
easier in the mouse and human genome due to the pub-
licly available ENCODE data [127]. As lncRNA identifica-
tion becomes easier due to improved sequencing and
bioinformatics tools, the number of annotated lncRNA
transcripts is rising sharply [4,128]. It is therefore a high
priority to determine which lncRNAs are functional and
which represent spurious transcription [109,129]. To date
only a relatively small number of mammalian lncRNAs
have clearly been shown to regulate gene expression and
most attention has centered on lncRNAs that act through
their transcription product [23]. With the recent demon-
stration that for some mammalian lncRNAs the act of
their transcription is sufficient for function [35], it be-
comes clear that there can be a number of lncRNAs acting
in a similar way. If the above described findings and ap-
proaches are used as guidelines, many new lncRNAs regu-
lating genes by the act of transcription are likely to be
discovered.
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